CRL

Oct 22, 4:38 PMCharles River, FDA and Labcorp launch research collaboration to develop preclinical tools to quantify and rank new drugs' abuse potential

Peers: LH TMO ICLR MEDP IQV SHC FTRE AZTA SDGR CERT

| Held by: VTI VOO VB RSP IVV VBR SPY IBB XLV DFAS

Scroll to Statements

Index	S&P 500
Market Cap	16.60B
Enterprise Value	19.47B
Income	-238.46M
Sales	4.00B
Book/sh	59.50
Cash/sh	4.53
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	19700
IPO	Jun 23, 2000

P/E	-
Forward P/E	27.18
PEG	2.32
P/S	4.15
P/B	5.85
P/C	76.71
P/FCF	44.80
EV/EBITDA	23.23
EV/Sales	4.87
Quick Ratio	1.04
Current Ratio	1.35
Debt/Eq	1.07
LT Debt/Eq	1.07
Option/Short	Yes / Yes

EPS (ttm)	-4.85
EPS next Y	12.80
EPS next Q	2.97
EPS this Y	10.69%
EPS next Y	12.45%
EPS next 5Y	11.70%
EPS past 3/5Y	- -
Sales past 3/5Y	0.33% 6.55%
EPS Y/Y TTM	-268.79%
Sales Y/Y TTM	-0.74%
EPS Q/Q	-102.91%
Sales Q/Q	-2.72%
Earnings	Nov 04 BMO
EPS/Sales Surpr.	10.13% 2.75%

Insider Own	1.12%
Insider Trans	-24.03%
Inst Own	123.18%
Inst Trans	-2.01%
ROA	-3.16%
ROE	-7.70%
ROIC	-4.06%
Gross Margin	32.63%
Oper. Margin	13.51%
Profit Margin	-5.96%
SMA20	12.44%
SMA50	17.77%
SMA200	58.97%
Trades

Shs Outstand	47.73M
Shs Float	47.20M
Short Float	6.10%
Short Ratio	2.88
Short Interest	2.88M
52W High	351.21 -0.98%
52W Low	146.20 137.89%
Volatility	5.40% 4.28%
ATR (14)	12.88
RSI (14)	73.90
Beta	1.38
Rel Volume	0.00
Avg Volume	999.70K
Volume	42

Perf Week	15.92%
Perf Month	18.76%
Perf Quarter	44.65%
Perf Half Y	103.11%
Perf YTD	74.34%
Perf Year	76.50%
Perf 3Y	98.65%
Perf 5Y	-19.09%
Perf 10Y	345.93%
Recom	1.85
Target Price	331.29
Prev Close	345.37
Price	347.78
Change %	0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-26	Resumed	UBS	Buy	$357
Aug-06-26	Upgrade	JP Morgan	Neutral → Overweight	$310
Jul-20-26	Downgrade	CLSA	Outperform → Hold	$219
Jun-17-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$220
May-29-26	Upgrade	CLSA	Hold → Outperform	$219
Apr-14-26	Initiated	RBC Capital Mkts	Outperform	$215
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy	$225
Nov-17-25	Upgrade	Argus	Hold → Buy
Nov-06-25	Upgrade	Robert W. Baird	Neutral → Outperform	$199
Oct-06-25	Upgrade	William Blair	Mkt Perform → Outperform
Oct-02-25	Upgrade	Barclays	Equal Weight → Overweight	$195
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$195
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$200
May-23-25	Upgrade	Redburn Atlantic	Neutral → Buy	$182
May-14-25	Upgrade	TD Cowen	Hold → Buy	$179
May-08-25	Upgrade	Evercore ISI	In-line → Outperform	$170
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$190 → $170
Mar-04-25	Upgrade	Citigroup	Sell → Neutral	$155 → $175
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral	$188
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Oct-22-26 04:30PM	Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment (Business Wire)
Oct-20-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.14% +9.33%
02:41PM	The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)
Oct-14-26 06:25AM	Charles River partners with Magellan Stem Cells on cell therapy (Pharmaceutical Technology)
Oct-13-26 08:00AM	Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development (Business Wire)
08:00AM	Loading…
Oct-09-26 08:00AM	Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call (Business Wire)
Oct-06-26 08:00AM	Charles River and Autolomous Partner to Transform Laboratory Execution Systems (Business Wire)
Oct-05-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +7.09%
Sep-24-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.17%
08:00AM	Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day (Business Wire)
Sep-17-26 08:00AM	Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines (Business Wire)
Sep-11-26 08:00AM	Charles River Laboratories to Present at Morgan Stanley and Baird Conferences (Business Wire)
Sep-08-26 08:00AM	Charles River Modernizes Endosafe Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite (Business Wire)
Aug-20-26 08:00AM	Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing (Business Wire)
Aug-06-26 09:48AM	Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls (The Fly)
05:01PM	Loading…
Aug-05-26 05:01PM	Charles River Laboratories International Inc (CRL) (Q2 2026) Earnings Call Highlights: First ... (GuruFocus.com) +11.36%
04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch)
04:16PM	Charles River Blows Out Of A Buy Zone After One Metric Hits A Four-Year High (Investor's Business Daily)
07:28AM	Charles River: Q2 Earnings Snapshot (Associated Press)
07:00AM	Charles River Laboratories Announces Second-Quarter 2026 Results (Business Wire)
Jul-29-26 04:52PM	Align Technology to add directors, launch review after deal with Elliott (Reuters)
Jul-28-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +7.19%
Jul-15-26 08:00AM	Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call (Business Wire)
Jul-13-26 08:00AM	Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches (Business Wire)
Jul-09-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch)
Jul-03-26 12:25PM	Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
Jun-24-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.31% +5.25%
08:05AM	S&P 500 opens in green as big tech stabilizes ahead of Micron earnings (Proactive)
02:18AM	FTSE 100 Live: Stocks creep higher as Segro surges, but gold tests 7-month lows (Proactive)
Jun-19-26 06:07AM	Charles River collaborates with Lilly TuneLab platform (Hospital Management)
08:00AM	Loading…
Jun-18-26 08:00AM	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise (Business Wire)
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Morgan Stanley favors Charles River Over IQVIA in CRO sector reset (Investing.com)
May-29-26 09:40AM	Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls (The Fly)
May-28-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +10.24%
May-27-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch)
May-15-26 04:30PM	Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors (MarketWatch) -5.20%
May-13-26 08:00AM	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions (Business Wire)
May-11-26 08:00AM	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow (Business Wire) -5.16%
May-07-26 07:11AM	Charles River: Q1 Earnings Snapshot (Associated Press)
07:00AM	Charles River Laboratories Announces First-Quarter 2026 Results (Business Wire)
Apr-30-26 08:00AM	Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities (Business Wire)
Apr-21-26 08:00AM	Charles River Highlights Effectiveness of VCGs in Toxicology (Business Wire)
Apr-16-26 08:00AM	Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call (Business Wire)
Apr-14-26 09:53AM	Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls (The Fly)
Apr-09-26 04:30PM	Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association (Business Wire)
Apr-06-26 08:55AM	NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX (PR Newswire)
Mar-10-26 10:30AM	Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand (Insider Monkey) -5.44%
Mar-09-26 11:33PM	A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack (StockStory)
Mar-05-26 10:34AM	Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds (Insider Monkey)
Mar-02-26 08:00AM	Charles River Laboratories to Present at TD Cowen and Barclays Conferences (Business Wire)
Feb-26-26 06:42AM	IQVIA to acquire Charles River drug discovery assets (Pharmaceutical Technology)
Feb-25-26 09:06AM	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans (Benzinga)
07:00AM	Charles River Laboratories Provides Update on Planned Divestitures (Business Wire)
Feb-24-26 02:38PM	Baird Maintains Outperform Rating on Charles River Laboratories International, Inc. (CRL) (Insider Monkey)
09:40AM	Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term (Zacks)
Feb-23-26 09:15AM	Investing in Charles River (CRL)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Feb-20-26 08:03AM	What Are Wall Street Analysts' Target Price for Charles River Laboratories Stock? (Barchart)
Feb-19-26 10:20PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
12:33AM	CRL Q4 Deep Dive: Flat Sales and Margin Pressures as Biotech Demand Recovers (StockStory)
Feb-18-26 04:06PM	Charles River Laboratories International Inc (CRL) Q4 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
12:49PM	Charles River Laboratories International Q4 Earnings Call Highlights (MarketBeat)
09:30AM	Here's What Key Metrics Tell Us About Charles River (CRL) Q4 Earnings (Zacks)
08:55AM	CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
08:10AM	Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:33AM	Charles River Laboratories (NYSE:CRL) Beats Q4 CY2025 Sales Expectations (StockStory)
07:16AM	Charles River: Q4 Earnings Snapshot (Associated Press Finance)
07:01AM	Charles River Laboratories Announces Executive Appointments (Business Wire)
07:00AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance (Business Wire)
Feb-16-26 10:05PM	Charles River Laboratories (CRL) Q4 Earnings: What To Expect (StockStory)
09:15AM	What Analyst Projections for Key Metrics Reveal About Charles River (CRL) Q4 Earnings (Zacks)
Feb-15-26 08:58AM	Analysts Are Bullish On Charles River Laboratories (CRL) Prospects (Insider Monkey)
Feb-13-26 09:39AM	Here's How Charles River Stock Is Placed Ahead of Q4 Earnings (Zacks)
07:01AM	Mariner selects State Streets Charles River wealth platform (Private Banker International)
Feb-12-26 02:27PM	Mariner Has Big Growth Plans. State Streets Charles River Is Supplying the Tech Platform. (Barrons.com)
Feb-11-26 08:21PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -8.42%
10:00AM	Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-10-26 11:34PM	1 S&P 500 Stock with Competitive Advantages and 2 We Ignore (StockStory)
Feb-08-26 11:01PM	Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Feb-02-26 07:15AM	Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates (Zacks)
Jan-27-26 08:10AM	HCA Healthcare (HCA) Beats Q4 Earnings Estimates (Zacks)
Jan-21-26 04:30PM	Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call (Business Wire)
08:00AM	Charles River Enters Manufacturing Collaboration with Gazi University (Business Wire)
Jan-20-26 11:04AM	Organon Secures FDA Approval Extending NEXPLANON Use to Five Years (Zacks)
11:00AM	Here's Why You Should Retain CLOV Stock in Your Portfolio for Now (Zacks)
Jan-19-26 05:59AM	What to Expect From Charles River Laboratories Next Quarterly Earnings Report (Barchart)
Jan-15-26 12:00PM	Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy (Zacks)
09:42AM	Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? (Zacks)
Jan-12-26 04:30PM	Charles River Laboratories Provides Business Updates (Business Wire)
08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks)
Jan-09-26 07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 08:00AM	Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan (Business Wire)
Jan-06-26 12:00PM	What Makes Charles River (CRL) a New Buy Stock (Zacks)
09:15AM	Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue? (Zacks)
Dec-22-25 03:00PM	Why Charles River Laboratories (CRL) Stock Is Trading Up Today (StockStory)
Dec-18-25 08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Oct 21 '26	Option Exercise	244.41	2,156	526,948	6,963	Oct 23 06:45 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Oct 21 '26	Sale	344.41	2,156	742,548	4,807	Oct 23 06:45 PM
FOSTER JAMES C	Director	Oct 22 '26	Proposed Sale	350.00	24,042	8,414,700		Oct 22 04:03 PM
Parisotto Shannon M	Officer	Oct 21 '26	Proposed Sale	344.41	2,156	742,548		Oct 21 04:05 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Oct 05 '26	Option Exercise	208.44	981	204,480	5,788	Oct 07 08:32 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Oct 05 '26	Sale	308.44	981	302,580	4,807	Oct 07 08:32 PM
Parisotto Shannon M	Officer	Oct 05 '26	Proposed Sale	314.56	981	308,580		Oct 05 04:25 PM
Coleman Glenn	EVP & Chief Financial Officer	Sep 30 '26	Buy	297.43	10	2,974	27,762	Oct 02 04:27 PM
FOSTER JAMES C	Director	Aug 25 '26	Option Exercise	199.42	33,561	6,692,845	65,157	Aug 27 04:21 PM
FOSTER JAMES C	Director	Aug 25 '26	Sale	300.00	33,561	10,068,300	31,596	Aug 27 04:21 PM
FOSTER JAMES C	Director	Aug 25 '26	Proposed Sale	299.93	33,561	10,065,951		Aug 25 04:10 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Aug 19 '26	Option Exercise	194.12	2,039	395,811	6,846	Aug 20 04:33 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Aug 19 '26	Sale	294.12	2,039	599,711	4,807	Aug 20 04:33 PM
Andrews Nancy C	Director	Aug 18 '26	Option Exercise	164.30	573	94,144	2,011	Aug 20 04:31 PM
Andrews Nancy C	Director	Aug 18 '26	Sale	285.24	573	163,443	1,438	Aug 20 04:31 PM
Parisotto Shannon M	Officer	Aug 19 '26	Proposed Sale	294.12	2,039	599,711		Aug 19 04:15 PM
Nancy C Andrews	Director	Aug 18 '26	Proposed Sale	285.00	573	163,305		Aug 18 11:06 AM
Girshick Birgit	Chief Executive Officer	Aug 11 '26	Option Exercise	179.66	6,500	1,167,790	42,513	Aug 13 04:37 PM
Girshick Birgit	Chief Executive Officer	Aug 11 '26	Sale	279.90	6,500	1,819,350	36,013	Aug 13 04:37 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Aug 11 '26	Option Exercise	179.66	3,714	667,257	8,521	Aug 13 04:34 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Aug 11 '26	Sale	279.66	3,714	1,038,657	4,807	Aug 13 04:34 PM
FOSTER JAMES C	Director	Aug 10 '26	Option Exercise	179.66	28,733	5,162,171	60,329	Aug 11 04:35 PM
FOSTER JAMES C	Director	Aug 10 '26	Sale	275.00	28,733	7,901,575	31,596	Aug 11 04:35 PM
Parisotto Shannon M	Officer	Aug 11 '26	Proposed Sale	279.66	3,714	1,038,657		Aug 11 04:07 PM
Girshick Birgit	Officer	Aug 11 '26	Proposed Sale	279.90	6,500	1,819,350		Aug 11 04:07 PM
Knell Michael Gunnar	SVP, Finance and CAO	Aug 06 '26	Option Exercise	196.12	2,345	459,909	14,197	Aug 10 04:40 PM
Knell Michael Gunnar	SVP, Finance and CAO	Aug 06 '26	Sale	260.38	6,645	1,730,250	11,852	Aug 10 04:40 PM
Creamer Victoria L	EVP & Chief People Officer	Aug 06 '26	Option Exercise	179.66	4,179	750,799	34,230	Aug 10 04:35 PM
Creamer Victoria L	EVP & Chief People Officer	Aug 06 '26	Sale	259.16	4,179	1,083,030	30,051	Aug 10 04:35 PM
FOSTER JAMES C	Director	Aug 10 '26	Proposed Sale	275.00	28,733	7,901,575		Aug 10 04:29 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Aug 05 '26	Sale	263.00	5,046	1,327,098	4,807	Aug 06 04:49 PM
Michael Knell	Officer	Aug 06 '26	Proposed Sale	260.00	6,645	1,727,700		Aug 06 03:09 PM
Victoria Creamer	Officer	Aug 06 '26	Proposed Sale	260.00	4,179	1,086,540		Aug 06 03:09 PM
Parisotto Shannon M	Officer	Aug 05 '26	Proposed Sale	263.00	5,046	1,327,098		Aug 05 04:02 PM
FOSTER JAMES C	Director	Jun 29 '26	Sale	225.00	75,000	16,875,000	31,596	Jul 01 04:59 PM
FOSTER JAMES C	Director	Jun 29 '26	Proposed Sale	225.00	75,000	16,875,000		Jun 29 04:44 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Mar 03 '26	Buy	174.54	25	4,364	27,448	Mar 04 04:39 PM

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

CEO & DirectorMs. Birgit Girshick

Corporate Senior VP & Chief Accounting OfficerMr. Michael Gunnar Knell

Corporate Executive Vice President of Corporate Development & StrategyMr. Joseph W. LaPlume J.D.

Corporate Executive VP & Chief People OfficerMs. Victoria L. Creamer

Corporate Executive VP & CFOMr. Glenn G. Coleman CPA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Charles River Laboratories International Inc

Upgrade your Finviz experience